CLINICAL_TRIALS
trial_result
· 2026-07-23
Clinical Trial Results: Optimized Erythropoietin (EPO) Treatment [Phase 2]
Summary
Phase 2 trial of optimized erythropoietin (EPO) for neonatal anemia completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Iowa | Conditions: Neonatal Anemia | Phase 2 | Status: COMPLETED | Results posted: 2026-07-23